IDORSIA LTD - PHASE 3 STUDY OF DARIDOREXANT SHOWS THAT 50 MG IMPROVED BOTH SLEEP AND DAYTIME FUNCTIONING COMPARED TO PLACEBO IN WOMEN DURING MENOPAUSAL TRANSITION AGE

Reuters · 01/05 16:46

Please log in to view news